The da Vinci Surgical System is a robotic surgical system
The da Vinci Surgical System is a robotic surgical system made by the American company Intuitive Surgical. Approved by the Food and Drug Administration (FDA) in 2000, it is designed to facilitate complex surgery using a minimally invasive approach, and is controlled by a surgeon from a console. System is commonly used for prostatectomies, and increasingly for cardiac valve repair and gynecologic surgical procedures.
According to the manufacturer, Da Vinci System is called “da Vinci” in part because Leonardo da Vinci’s “study of human anatomy eventually led to the design of the first known robot in history.”
Da Vinci Surgical Systems operate in hospitals worldwide, with an estimated 200,000 surgeries conducted in 2012, most commonly for hysterectomies and prostate removals. As of September 30, 2016, there was an installed base of 3,803 units worldwide – 2,501 in United States, 644 in Europe, 476 in Asia, and 182 in the rest of world.The “Si” version of the system costs on average slightly under US$2 million, in addition to several hundred thousand dollars of annual maintenance fees. DA Vinci system has been criticised for its cost and for a number of issues with its surgical performance.